Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2431 AL 2445

Systemic Rejuvenating Interventions: Perspectives on Neuroinflammation and Blood-Brain Barrier Integrity

de Rezende VL, de Aguiar da Costa M, Martins CD, Mathias K, Gonçalves CL, Barichello T, Petronilho F.

Neurochem Res. 2025 Mar 4;50(2):112. doi: 10.1007/s11064-025-04361-7.

Biofunctionalized nanomaterials for Parkinson's disease theranostics: potential for efficient PD biomarker detection and effective therapy

Sabnam S, Kumar R, Pranav.

Biomater Sci. 2025 Apr 29;13(9):2201-2234. doi: 10.1039/d5bm00179j.

Breath hydrogen levels in patients with Parkinson's disease: A pilot cross-sectional study

Baltic S, Todorovic N, Popovic S, Galic V, Semnic M, Ostojic SM.

Parkinsonism Relat Disord. 2025 Apr;133:107353. doi: 10.1016/j.parkreldis.2025.107353. Epub 2025 Feb 27.

Efficacy and safety of newer-generation antidepressants medications in Parkinson's disease with depression - A meta-analysis of randomized controllde trials

Xu F, Zhou W, Luo H, Su D, Dong M, Hu Y, Lou M, Li G, Zhang Y.

J Psychiatr Res. 2025 Apr;184:48-55. doi: 10.1016/j.jpsychires.2025.02.044. Epub 2025 Feb 25.

Extracellular vesicles: new horizons in neurodegeneration

Chen J, Tian C, Xiong X, Yang Y, Zhang J.

EBioMedicine. 2025 Mar;113:105605. doi: 10.1016/j.ebiom.2025.105605. Epub 2025 Mar 3.

2024 VCP International Conference: Exploring multi-disciplinary approaches from basic science of valosin containing protein, an AAA+ ATPase protein, to the therapeutic advancement for VCP-associated multisystem proteinopathy

Peck A, Dadi A, Yavarow Z, Alfano LN, Anderson D, Arkin MR, Chou TF, D'Ambrosio ES, Diaz-Manera J, Dudley JP, Elder AG, Ghoshal N, Hart CE, Hart MM, Huryn DM, Johnson AE, Jones KB, Kimonis V, Kiskinis E, Lee EB, Lloyd TE, Mapstone M, Martin A, Meyer H, Mozaffar T, Onyike CU, Pfeffer G, Pindon A, Raman M, Richard I, Rubinsztein DC, Schiava M, Schütz AK, Shen PS, Southworth DR, Staffaroni AM, Taralio-Gravovac M, Weihl CC, Yao Q, Ye Y, Peck N.

Neurobiol Dis. 2025 Apr;207:106861. doi: 10.1016/j.nbd.2025.106861. Epub 2025 Mar 2.

Closing the loop in DBS: A data-driven approach

Acharyya P, Daley KW, Choi JW, Wilkins KB, Karjagi S, Cui C, Seo G, Abay AK, Bronte-Stewart HM.

Parkinsonism Relat Disord. 2025 May;134:107348. doi: 10.1016/j.parkreldis.2025.107348. Epub 2025 Feb 21.

A case report of palatal tremor in progressive supranuclear palsy

Cataniag P, Ong JN, Diesta CC.

Parkinsonism Relat Disord. 2025 Jul;136:107324. doi: 10.1016/j.parkreldis.2025.107324. Epub 2025 Feb 13.

Delving Into Nanoparticle Systems for Enhanced Drug Delivery Technologies

Abaidullah N, Muhammad K, Waheed Y.

AAPS PharmSciTech. 2025 Mar 4;26(3):74. doi: 10.1208/s12249-025-03063-1.

Deciphering the Neuroprotective Action of Bee Venom Peptide Melittin: Insights into Mechanistic Interplay

Kadyan P, Singh L.

Mol Neurobiol. 2025 Jul;62(7):8738-8751. doi: 10.1007/s12035-025-04808-6. Epub 2025 Mar 4.

A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson's disease

Li D, Yau WY, Chen S, Wilton S, Mastaglia F.

NPJ Parkinsons Dis. 2025 Mar 4;11(1):42. doi: 10.1038/s41531-025-00887-3.

Role of iron in brain development, aging, and neurodegenerative diseases

Gao Q, Zhou Y, Chen Y, Hu W, Jin W, Zhou C, Yuan H, Li J, Lin Z, Lin W.

Ann Med. 2025 Dec;57(1):2472871. doi: 10.1080/07853890.2025.2472871. Epub 2025 Mar 4.

Local Field Potential Biomarkers of Non-Motor Symptoms in Parkinson's Disease: Insights From the Subthalamic Nucleus in Deep Brain Stimulation

Gobeil MA, Guillemette A, Silhadi M, Charbonneau L, Bergeron D, Dominguez-Vargas AU, Dancause N, Jodoin N, Assi EB, Amzica F, Obaid S, Fournier-Gosselin MP.

Eur J Neurosci. 2025 Mar;61(5):e70046. doi: 10.1111/ejn.70046.

Device-assisted therapies for Parkinson disease

Mouchaileh N, Cameron J.

Aust Prescr. 2025 Feb;48(1):10-17. doi: 10.18773/austprescr.2025.003.

Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications

Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V, Panda SK, Kerry RG, Duttaroy AK, Jena AB.

Acta Pharm Sin B. 2025 Jan;15(1):15-34. doi: 10.1016/j.apsb.2024.10.004. Epub 2024 Oct 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias